Orchev Pharma Pvt. Ltd.

Established in 1989, this company is a leading producer of the APIs Famotidine, Ranitidine HCl and Telmisartan, with a facility approved by the US FDA (June 2025), CEP, Korean FDA, and COFEPRIS Mexico, among others, helping meet customer needs in more than 55 countries worldwide. The company is the largest manufacturer of Famotidine API, with capacity of 150 metric tons per year and its intermediates, holding approvals including CEP 2022-307, EIR-USFDA, US-DMF #036764, China DMF and Korean DMF approvals, and producing the Famotidine intermediates ITU, IFM and FIT.